REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31/03/2025
Voltar para busca
Dado oficial do USPTO
HEIDELBERG PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
01/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
03/08/2018
Data de registro
31/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/03/2020
Última transação
01/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Ladenburg, DE
Examinador
KEATING, MICHAEL
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a blue circle within another light blue partial circular design, to the right of which appears the stylized word "Heidelberg" in blue letters. Appearing within the partial circular design, and under the word "Heidelberg" is the stylized word "PHARMA" in blue upper-case letters.
Titulares e representantes
Titulares
Heidelberg Pharma AG
Representantes
Todd A. Sullivan Hayes Soloway P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicalsmonoclonal antibodies for in vitro scientific or research use
Classe 5
Pharmaceutical preparations for the treatment of immuno oncological disorderscancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposesfor the treatment of cancer; pharmaceutical preparations for human usefor the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
Classe 42
Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies
Classe 44
Pharmaceutical advice; pharmaceutical servicesproviding pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/02/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/01/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
31/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2020
PUBO
PUBLISHED FOR OPPOSITION
14/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/11/2019
ALIE
ASSIGNED TO LIE
16/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2019
GNRT
NON-FINAL ACTION E-MAILED
09/05/2019
CNRT
NON-FINAL ACTION WRITTEN
09/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/11/2018
GNRT
NON-FINAL ACTION E-MAILED
26/11/2018
CNRT
NON-FINAL ACTION WRITTEN
26/11/2018
DOCK
ASSIGNED TO EXAMINER
21/11/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2018
NWAP
NEW APPLICATION ENTERED
07/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEIDELBERG PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.